HCA Healthcare, Inc.

HCA· NYSE· Services-General Medical & Surgical Hospitals, NEC

Market cap
–
P/FCF
–
EV/Sales
–
FCF margin
10.2%
ROIC, 5 yr avg
–
Revenue, 5 yr CAGR
+8.0%
We record prices for the companies we cover; HCA is not one of them yet.

Company statistics

From the 10-Ks, computed in code · point at a figure for its formula

Profile · FY2025

Market cap
–
Enterprise value
–
Diluted shares
239.5M
Revenue
$75.6B
Free cash flow
$7.7B
Owner earnings
$7.3B

Valuation · FY2025

P/E
–
P/FCF
–
P/Owner earnings
–
EV/Sales
–
EV/FCF
–
P/B
–

Margins · FY2025

Gross
–
Operating
–
Net
9.0%
Free cash flow
10.2%
Owner earnings
9.6%
Stock pay
0.5%

Returns

ROIC, FY2025
–
ROIC, 5 yr avg
–
ROE, FY2025
–
ROE, 5 yr avg
–

Growth (CAGR)

Revenue, 3 yr
7.9%
Revenue, 5 yr
8.0%
Revenue, 9 yr
6.9%
Diluted EPS, 3 yr
13.9%
Diluted EPS, 5 yr
21.0%
Diluted EPS, 9 yr
16.3%
Free cash flow, 3 yr
23.1%
Free cash flow, 5 yr
3.8%
Free cash flow, 9 yr
11.5%

Financial health · FY2025

Cash and investments
$1.0B
Total debt
$41.6B
Net debt
$40.6B
Debt/Equity
–
Debt/FCF
5.4x

Shareholder returns · FY2025

Dividend yield
–
Payout ratio
10.0%
Buyback yield
–
Shareholder yield
–
Share count, 5 yr
-7.0%

Financials: ten years from the 10-Ks

Reported numbers open their filing · computed ones show the formula · ˢ split-adjusted

Revenue

$75.6B

+6.9% a year over 9 years

FY2016: Revenue $41.5BFY2017: Revenue $43.6BFY2018: Revenue $46.7BFY2019: Revenue $51.3BFY2020: Revenue $51.5BFY2021: Revenue $58.8BFY2022: Revenue $60.2BFY2023: Revenue $65.0BFY2024: Revenue $70.6BFY2025: Revenue $75.6B
FY2016FY2025

Margins

9.0%

FY2025

FY2016: Net 7.0%FY2017: Net 5.1%FY2018: Net 8.1%FY2019: Net 6.8%FY2020: Net 7.3%FY2021: Net 11.8%FY2022: Net 9.4%FY2023: Net 8.1%FY2024: Net 8.2%FY2025: Net 9.0%
FY2016FY2025

Free cash flow and owner earnings

Free cash flow$7.7BOwner earnings$7.3B

Free cash flow +11.5% a year

FY2016: Free cash flow $2.9B, Owner earnings $2.6BFY2017: Free cash flow $2.4B, Owner earnings $2.1BFY2018: Free cash flow $3.2B, Owner earnings $2.9BFY2019: Free cash flow $3.4B, Owner earnings $3.1BFY2020: Free cash flow $6.4B, Owner earnings $6.0BFY2021: Free cash flow $5.4B, Owner earnings $4.9BFY2022: Free cash flow $4.1B, Owner earnings $3.8BFY2023: Free cash flow $4.7B, Owner earnings $4.4BFY2024: Free cash flow $5.6B, Owner earnings $5.3BFY2025: Free cash flow $7.7B, Owner earnings $7.3B
FY2016FY2025

Diluted shares

239.5M

-39.5% over 9 years, net buybacks

FY2016: Diluted shares 395.9MFY2017: Diluted shares 372.2MFY2018: Diluted shares 355.3MFY2019: Diluted shares 348.2MFY2020: Diluted shares 343.6MFY2021: Diluted shares 328.8MFY2022: Diluted shares 294.7MFY2023: Diluted shares 276.4MFY2024: Diluted shares 261.8MFY2025: Diluted shares 239.5M
FY2016FY2025

Net debt (below zero)

-$40.6B

$40.6B more debt than cash

FY2016: Net cash -$30.7BFY2017: Net cash -$32.3BFY2018: Net cash -$32.3BFY2019: Net cash -$33.1BFY2020: Net cash -$29.1BFY2021: Net cash -$33.0BFY2022: Net cash -$37.2BFY2023: Net cash -$38.7BFY2024: Net cash -$41.1BFY2025: Net cash -$40.6B
FY2016FY2025

Every figure, year by year

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
The business
Revenue$41.5B$43.6B$46.7B$51.3B$51.5B$58.8B$60.2B$65.0B$70.6B$75.6B
Revenue growth–5.1%7.0%10.0%0.4%14.0%2.5%7.9%8.7%7.1%
Gross margin––––––––––
Operating margin––––––––––
Net income$2.9B$2.2B$3.8B$3.5B$3.8B$7.0B$5.6B$5.2B$5.8B$6.8B
Net margin7.0%5.1%8.1%6.8%7.3%11.8%9.4%8.1%8.2%9.0%
Diluted EPS$7.30$5.95$10.66$10.07$10.93$21.16$19.15$18.97$22.00$28.33
Return on invested capital?––––––––––
Cash
Operating cash flow$5.7B$5.4B$6.8B$7.6B$9.2B$9.0B$8.5B$9.4B$10.5B$12.6B
Capital expenditure$2.8B$3.0B$3.6B$4.2B$2.8B$3.6B$4.4B$4.7B$4.9B$4.9B
Free cash flow$2.9B$2.4B$3.2B$3.4B$6.4B$5.4B$4.1B$4.7B$5.6B$7.7B
Stock-based compensation$251.0M$270.0M$268.0M$347.0M$362.0M$440.0M$341.0M$262.0M$360.0M$401.0M
Owner earnings?$2.6B$2.1B$2.9B$3.1B$6.0B$4.9B$3.8B$4.4B$5.3B$7.3B
Free cash flow per share$7.31$6.48$8.97$9.89$18.62$16.37$14.01$16.96$21.54$32.12
Capital allocation
Dividends paid–$0$487.0M$550.0M$153.0M$624.0M$653.0M$661.0M$690.0M$679.0M
Share repurchases$2.8B$2.1B$1.5B$1.0B$441.0M$8.2B$7.0B$3.8B$6.0B$10.1B
Diluted shares395.9M372.2M355.3M348.2M343.6M328.8M294.7M276.4M261.8M239.5M
Share count change?-7.2%-6.0%-4.5%-2.0%-1.3%-4.3%-10.4%-6.2%-5.3%-8.5%
Balance sheet
Cash and equivalents$646.0M$732.0M$502.0M$621.0M$1.8B$1.5B$908.0M$935.0M$1.9B$1.0B
Short-term investments––––$116.0M$103.0M––––
Total debt$31.4B$33.1B$32.8B$33.7B$31.0B$34.6B$38.1B$39.6B$43.0B$41.6B
Net debt$30.7B$32.3B$32.3B$33.1B$29.1B$33.0B$37.2B$38.7B$41.1B$40.6B
Shareholders' equity-$7.3B-$6.8B-$5.0B-$2.8B$572.0M-$933.0M-$2.8B-$1.8B-$2.5B-$6.0B

Latest filings

All on EDGAR
2026-10-2910-QQuarterly report
2026-10-278-KEarnings release
2026-07-2810-QQuarterly report
2026-07-248-KEarnings release
2026-07-148-KEarnings release
2026-04-2910-QQuarterly report
2026-04-248-KEarnings release
2026-03-13DEF 14AProxy statement
2026-02-1010-KAnnual report
2026-01-278-KEarnings release

More from our coverage

All coverage